Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system (Q35900223)

11 August 2017

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system (English)

1 reference

11 August 2017

Bacteroides fragilis

1 reference

1 reference

Zabinski RA

1

1 reference

11 August 2017

Vance-Bryan K

2

1 reference

11 August 2017

Krinke AJ

3

1 reference

11 August 2017

Walker KJ

4

1 reference

11 August 2017

Moody JA

5

1 reference

11 August 2017

Rotschafer JC

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

37

1 reference

11 August 2017

11

1 reference

11 August 2017

2454-2458

1 reference

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192408

Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model

11 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8285633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fluoroquinolone antimicrobial agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8285633

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.11.2454

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8285633

1 reference